Position in PFE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$152,826,994
-$25,182,570 QoQ
Shares Held
6,346,636
+0.1% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#77
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,805,415,142 across 12 Drug Manufacturers - General names. PFE ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255,719 | $1,506,147,163 | |
| 2 | JNJ |
Johnson & Johnson
|
3,383,935 | $859,417,971 | |
| 3 | ABBV |
AbbVie Inc.
|
2,684,208 | $675,454,100 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,751,479 | $610,565,050 | |
| 5 | NVS |
Novartis AG
|
1,565,796 | $245,391,548 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,793,779 | $226,626,038 | |
| 7 | AMGN |
Amgen Inc
|
614,341 | $222,465,162 | |
| 8 | PFE |
Pfizer Inc
This page
|
6,346,636 | $152,826,994 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,826,994 | 6,346,636 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $178,009,564 | 6,339,372 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $157,039,518 | 6,306,808 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $156,390,124 | 6,137,760 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $150,054,931 | 6,190,385 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $161,457,559 | 6,371,648 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $169,894,908 | 6,403,879 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $263,015,950 | 9,088,319 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $292,044,801 | 10,437,627 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $307,880,671 | 11,094,799 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $320,785,837 | 11,142,266 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $392,598,825 | 11,835,961 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $436,815,992 | 11,908,833 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $476,984,476 | 11,690,796 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $594,031,672 | 11,593,124 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $515,431,884 | 11,778,608 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $617,355,751 | 11,774,857 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $580,251,981 | 11,208,267 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $650,923,620 | 11,023,262 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $540,623,269 | 12,569,711 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $460,824,305 | 11,767,730 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $410,909,682 | 11,341,697 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $437,713,083 | 11,891,146 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $464,408,901 | 12,654,206 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $438,573,735 | 13,412,027 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $418,595,486 | 12,824,634 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||